These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 874518)

  • 1. HLA antigens and myasthenia gravis in Japan.
    Yoshida T; Tsuchiya M; Ono A; Yoshimatsu H; Satoyoshi E; Tsuji K
    J Neurol Sci; 1977 Jun; 32(2):195-201. PubMed ID: 874518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations.
    Spurkland A; Gilhus NE; Rønningen KS; Aarli JA; Vartdal F
    Tissue Antigens; 1991 Feb; 37(2):90-3. PubMed ID: 2057938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
    Humbert P; Dupond JL; Mallet H; Leconte des Floris R
    Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
    Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
    Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HL-A antigens on hyperplastic and neoplastic thymic tissue.
    Naeim F; Stoddard A; Fritze D; Herrmann C; Zeller E; Walford RL
    Cancer Res; 1974 Mar; 34(3):654-6. PubMed ID: 4812266
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA antigens and myasthenia gravis in north India.
    Mehra NK; Ahuja GK; Taneja V; Vaidya MC
    J Neurol Neurosurg Psychiatry; 1983 Apr; 46(4):361-4. PubMed ID: 6842252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.
    Oosterhuis HJ; Feltkamp TE; van Rossum AL; van den Berg-Loonen PM; Nijenhuis LE
    Ann N Y Acad Sci; 1976; 274():468-74. PubMed ID: 1085589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymectomy for elderly myasthenia gravis patients.
    Kirschner PA
    Ann Thorac Surg; 2000 Jan; 69(1):313-5. PubMed ID: 10654552
    [No Abstract]   [Full Text] [Related]  

  • 13. The biologic significance of HL-A antigen markers in myasthenia gravis.
    Fritze D; Herrmann C; Naeim F; Smith GS; Zeller E; Walford RL
    Ann N Y Acad Sci; 1976; 274():440-50. PubMed ID: 1066993
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.
    Savino W; Manganella G; Verley JM; Wolff A; Berrih S; Levasseur P; Binet JP; Dardenne M; Bach JF
    J Clin Invest; 1985 Sep; 76(3):1140-6. PubMed ID: 2413072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic associations between myasthenia gravis and the HL-A system.
    Pirskanen R
    J Neurol Neurosurg Psychiatry; 1976 Jan; 39(1):23-33. PubMed ID: 1255208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis.
    Carlsson B; Wallin J; Pirskanen R; Matell G; Smith CI
    Immunogenetics; 1990; 31(5-6):285-90. PubMed ID: 1973409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gm allotypes in myasthenia gravis.
    Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
    Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
    Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
    J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.